Which has the lower trailing P/E, BIIB or IQV?

BIIB has the lower trailing P/E: BIIB trades at 1.37 and IQV at 29.50. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIIB or IQV?

Over the past five years, IQV grew revenue faster — BIIB at a -3.19% CAGR versus IQV at 5.61%.

Is BIIB or IQV more profitable?

BIIB runs the higher net margin — BIIB at 8.39% versus IQV at 8.10%.

How have BIIB and IQV total returns compared?

Over the past 10 years, BIIB delivered -3.27% and IQV delivered 11.84% annualized total return. Past performance doesn't predict future results.

Biogen Inc. (BIIB) vs IQVIA Holdings Inc. (IQV)

A side-by-side comparison of Biogen Inc. and IQVIA Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.

BIIB

Biogen Inc.

$30.70B

$207.93HealthcareDelayed quote: Jul 30, 2026, 4:00 PM EDT

IQV

IQVIA Holdings Inc.

$39.15B

$237.82HealthcareDelayed quote: Jul 30, 2026, 3:59 PM EDT

Total return — BIIB vs IQV

growth of $100 · dividends reinvested · last 13y

BIIB -5.0%IQV +464.7%IQV compounded faster

Log scale — wide-divergence pair

BIIB IQV

BIIB vs IQV: by the numbers

•IQV is the larger company ($39.15B vs $30.70B market cap).
•BIIB trades at the lower trailing earnings multiple (1.37 vs 29.50 P/E), one valuation lens rather than an overall verdict.
•BIIB converts more revenue to profit (8.39% vs 8.10% net margin).
•IQV grew revenue faster over the past five years (5.61% vs -3.19% CAGR).

Metrics side by side

Valuation

Metric	BIIB	IQV
P/E ratio	1.37	29.50
Forward P/E	16.29	18.36
P/S ratio	3.10	2.36
P/B ratio	1.65	6.50
PEG ratio	N/A	6.34
EV / EBITDA	13.86	15.60
FCF yield	8.60%	7.33%

Profitability

Metric	BIIB	IQV
Gross margin	70.47%	26.23%
Operating margin	19.14%	13.57%
Net margin	8.39%	8.10%
ROE	4.48%	22.28%
ROIC	6.62%	8.23%

Growth (annualized)

Metric	BIIB	IQV
Revenue CAGR (5Y)	-3.19%	5.61%
EPS CAGR (5Y)	-18.67%	40.21%
FCF CAGR (5Y)	-11.63%	6.92%
Total return CAGR (5Y)	-8.64%	-0.81%

Frequently asked

Which has the lower trailing P/E, BIIB or IQV?: BIIB has the lower trailing P/E: BIIB trades at 1.37 and IQV at 29.50. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIIB or IQV?: Over the past five years, IQV grew revenue faster — BIIB at a -3.19% CAGR versus IQV at 5.61%.
Is BIIB or IQV more profitable?: BIIB runs the higher net margin — BIIB at 8.39% versus IQV at 8.10%.
How have BIIB and IQV total returns compared?: Over the past 10 years, BIIB delivered -3.27% and IQV delivered 11.84% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIIB analysis Full IQV analysis Interactive comparison tool

Dig into the metrics

Biogen P/E ratio IQVIA P/E ratio Biogen dividend yield IQVIA dividend yield Biogen ROE IQVIA ROE Biogen operating margin IQVIA operating margin Biogen revenue growth IQVIA revenue growth Biogen free cash flow IQVIA free cash flow

Biogen & IQVIA appear in these rankings

Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.